Fri, May 12, 2023
Thu, May 11, 2023
Wed, May 10, 2023

Andrew Fein Reiterated (SYRS) at Strong Buy and Held Target at $15 on, May 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-15-on-may-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy and Held Target at $15 on, May 11th, 2023.

Andrew has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $13 on, Friday, March 3rd, 2023

Publication Contributing Sources